Clinical Trial Update: CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CD19-targeted T-CAR therapy in children and young adults with relapsed/refractory B-ALL, currently in Phase 1/Phase 2 with unknown sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Lymphocytic Leukemia Pediatric

Drugs mentioned

• CD19 T-CAR (CD19-directed chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: B-cell Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Pediatric | Phase 1, Phase 2 | Status: UNKNOWN